Aligos Therapeutics, Inc. (ALGS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$6.56
Day's range
$7.3

Aligos Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
DEEP TRACK CAPITAL, LP 08/14/2026 444.11 K $2.56 M   0.00% 4.26%
ALYESKA INVESTMENT GROUP, L.P. 08/14/2026 412.00 K $2.38 M   0.00% 3.95%
SIO CAPITAL MANAGEMENT, LLC 08/14/2026 327.24 K $1.89 M   0.00% 3.14%
MARSHALL WACE, LLP 08/13/2026 246.58 K $1.42 M   -7.70% 2.36%
WOODLINE PARTNERS LP 08/14/2026 177.36 K $1.02 M   0.00% 1.70%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 175.54 K $1.01 M   -1.53% 1.68%
BAKER BROS. ADVISORS LP 08/14/2026 83.06 K $479.23 K   0.00% 0.80%
HHLR ADVISORS, LTD. 08/14/2026 76.25 K $439.95 K   0.00% 0.73%
D. E. SHAW & CO., INC. 08/14/2026 66.46 K $383.49 K   505.42% 0.64%
UBS GROUP AG 08/13/2026 59.99 K $346.12 K   61.86% 0.58%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 47.17 K $272.32 K   -5.61% 0.45%
JANE STREET GROUP, LLC 08/14/2026 32.40 K $186.96 K   100.00% 0.31%
BLACKROCK, INC. 08/07/2026 30.29 K $174.79 K   132.30% 0.29%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 28.61 K $165.09 K   0.62% 0.27%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 21.04 K $121.42 K   100.00% 0.20%
VERITION FUND MANAGEMENT LLC 08/14/2026 18.89 K $108.98 K   0.00% 0.18%
TREXQUANT INVESTMENT LP 08/14/2026 12.34 K $71.20 K   100.00% 0.12%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 10.80 K $62.32 K   -89.25% 0.10%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 08/13/2026 10.00 K $57.70 K   0.00% 0.10%
FEDERATION DES CAISSES DESJARDINS DU QUEBEC 08/14/2026 4.65 K $26.83 K   389.47% 0.04%
GOLDEN STATE WEALTH MANAGEMENT, LLC 07/22/2026 2.67 K $15.43 K   0.00% 0.03%
ROYAL BANK OF CANADA 08/14/2026 2.13 K $12.00 K   0.00% 0.02%
CITIGROUP INC 08/03/2026 1.81 K $10.43 K   100.00% 0.02%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 359 $2.07 K   452.31% 0.00%
JPMORGAN CHASE & CO 08/12/2026 344 $1.87 K   -48.96% 0.00%
MORGAN STANLEY 08/13/2026 204 $1.18 K   -6.42% 0.00%
SBI SECURITIES CO., LTD. 07/23/2026 126 $727   384.62% 0.00%
WELLS FARGO & COMPANY/MN 08/14/2026 100 $577   -85.71% 0.00%
FMR LLC 08/13/2026 10 $58   100.00% 0.00%
ZRC WEALTH MANAGEMENT, LLC 07/08/2026 4 $24   0.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 3 $17   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 08/14/2026 0 $0   -100.00% 0.00%
TWO SIGMA INVESTMENTS, LP 08/14/2026 0 $0   -100.00% 0.00%
LPL FINANCIAL LLC 08/07/2026 0 $0   -100.00% 0.00%
CITADEL ADVISORS LLC 09/02/2026 0 $0   -100.00% 0.00%
QUADRATURE CAPITAL LTD 08/07/2026 0 $0   -100.00% 0.00%
VANGUARD GLOBAL ADVISERS, LLC 08/13/2026 0 $0   -100.00% 0.00%
XTX TOPCO LTD 08/14/2026 0 $0   -100.00% 0.00%
SUMMITTX CAPITAL, L.P. 08/14/2026 0 $0   -100.00% 0.00%

Aligos Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 46 institutional investors and hedge funds held shares of Aligos Therapeutics Inc. The most heavily invested institutionals were:

Deep Track Capital, LP: 444,110

Alyeska Investment Group, L.P.: 412,000

Sio Capital Management, LLC: 327,237

MARSHALL WACE, LLP: 246,579

Woodline Partners LP: 177,362

VANGUARD CAPITAL MANAGEMENT LLC: 175,543

21.98% of Aligos Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 5.79 M shares in the last 24 months. This purchase volume represents approximately $40.70 M in transactions.